Lili Fu

Wenzhou, 325000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

10-Hydroxy-2-decenoic acid ameliorates LPS-induced acute lung injury through targeting MD2-mediated inflammatory signaling pathways.

10-Hydroxy-2-decenoic acid ameliorates LPS-induced acute lung injury through targeting MD2-mediated inflammatory signaling pathways.

Journal: Toxicology and applied pharmacology

Published: July 23, 2025

Dl-3-n-butylphthalide attenuates acute myocardial infarction by inhibiting the binding of Nrf2/Keap1.

Dl-3-n-butylphthalide attenuates acute myocardial infarction by inhibiting the binding of Nrf2/Keap1.

Journal: Toxicology and applied pharmacology

Published: December 18, 2024

Dl-3-n-butylphthalide attenuates DOX-induced cardiotoxicity in mice by inhibiting Nrf2/Keap1 complex formation.

Dl-3-n-butylphthalide attenuates DOX-induced cardiotoxicity in mice by inhibiting Nrf2/Keap1 complex formation.

Journal: Frontiers in pharmacology

Published: December 09, 2024

Bicyclol mitigates lipopolysaccharide-induced acute lung injury through myeloid differentiation factor 88 inhibition.

Bicyclol mitigates lipopolysaccharide-induced acute lung injury through myeloid differentiation factor 88 inhibition.

Journal: Toxicology and applied pharmacology

Published: March 04, 2024

Structural basis for FGF hormone signalling.

Structural basis for FGF hormone signalling.

Journal: Nature

Published: September 06, 2022

A novel indazole derivative, compound Cyy-272, attenuates LPS-induced acute lung injury by inhibiting JNK phosphorylation.

A novel indazole derivative, compound Cyy-272, attenuates LPS-induced acute lung injury by inhibiting JNK phosphorylation.

Journal: Toxicology and applied pharmacology

Published: January 24, 2021

Compound 15c, a Novel Dual Inhibitor of EGFRL858R/T790M and FGFR1, Efficiently Overcomes Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance of Non-Small-Cell Lung Cancers.

Compound 15c, a Novel Dual Inhibitor of EGFRL858R/T790M and FGFR1, Efficiently Overcomes Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance of Non-Small-Cell Lung Cancers.

Journal: Frontiers in pharmacology

Published: October 22, 2019

Molecular basis for receptor tyrosine kinase A-loop tyrosine transphosphorylation.

Molecular basis for receptor tyrosine kinase A-loop tyrosine transphosphorylation.

Journal: Nature chemical biology

Published: August 03, 2019

Discovery of new MD2-targeted anti-inflammatory compounds for the treatment of sepsis and acute lung injury.

Discovery of new MD2-targeted anti-inflammatory compounds for the treatment of sepsis and acute lung injury.

Journal: European journal of medicinal chemistry

Published: July 12, 2017

α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling.

α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling.

Journal: Nature

Published: June 06, 2017

Synthesis and biological evaluation of allylated mono-carbonyl analogues of curcumin (MACs) as anti-cancer agents for cholangiocarcinoma.

Synthesis and biological evaluation of allylated mono-carbonyl analogues of curcumin (MACs) as anti-cancer agents for cholangiocarcinoma.

Journal: Bioorganic & medicinal chemistry letters

Published: August 15, 2016

A novel imidazopyridine derivative, X22, attenuates sepsis-induced lung and liver injury by inhibiting the inflammatory response in vitro and in vivo.

A novel imidazopyridine derivative, X22, attenuates sepsis-induced lung and liver injury by inhibiting the inflammatory response in vitro and in vivo.

Journal: Drug design, development and therapy

Published: July 09, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026